Literature DB >> 8145539

Basic fibroblast growth factor in the early human burn wound.

N S Gibran1, F F Isik, D M Heimbach, D Gordon.   

Abstract

The role of endogenous growth factors in normal wound healing is not clear. Most of the data on growth factors in healing wounds have been obtained from the application of recombinant exogenous growth factors to animal and human wounds. We describe the immunolocalization of basic fibroblast growth factor (bFGF) in the injured dermis of skin from patients with partial and full-thickness burns. Three antibodies demonstrate an extracellular staining pattern of bFGF corresponding to areas of tissue injury that was most intense in specimens collected between 4 and 11 days post-burn injury. In contrast, bFGF staining appeared markedly decreased by Postburn Day 17 and was more consistent with uninjured tissue in a 30-day-old burn that had virtually reepithelialized. Basic FGF staining in the non-burned skin from the same patients was restricted to the dermal capillary basement membranes and the sweat glands, which is consistent with other reports of immunoreactive bFGF localization in normal adult skin. The immunohistochemical results were confirmed with Western immunoblots of the same tissue. The major band at 16.5 kDa, which is within the recognized range of the bFGF molecule's several forms, was detected in both burned and unburned tissue from the same patient. These findings support the hypothesis that bFGF is a presynthesized mediator that is stored in either the cells or extracellular matrix, is released locally from sites of direct injury, and may be important in early wound healing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8145539     DOI: 10.1006/jsre.1994.1036

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  17 in total

1.  The incorporation of bFGF mediated by heparin into PCL/gelatin composite fiber meshes for guided bone regeneration.

Authors:  Ji-hye Lee; Young Jun Lee; Hyeong-jin Cho; Dong Wan Kim; Heungsoo Shin
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

2.  Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2.

Authors:  S Ortega; M Ittmann; S H Tsang; M Ehrlich; C Basilico
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

3.  Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells.

Authors:  R Tsou; F F Isik
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

Review 4.  A cytokine axis regulates elastin formation and degradation.

Authors:  Erin P Sproul; W Scott Argraves
Journal:  Matrix Biol       Date:  2012-11-13       Impact factor: 11.583

5.  In situ loading of basic fibroblast growth factor within porous silica nanoparticles for a prolonged release.

Authors:  Jin Zhang; Lynne-Marie Postovit; Dashan Wang; Richard B Gardiner; Richard Harris; Muminmd Abdul; Anualice Thomas
Journal:  Nanoscale Res Lett       Date:  2009-07-25       Impact factor: 4.703

6.  Ontogeny and characterization of factor XIIIa+ cells in developing human skin.

Authors:  N S Gibran; B J Nickoloff; K A Holbrook
Journal:  Anat Embryol (Berl)       Date:  1996-01

Review 7.  Wound-healing studies in transgenic and knockout mice.

Authors:  Richard Grose; Sabine Werner
Journal:  Mol Biotechnol       Date:  2004-10       Impact factor: 2.695

8.  Autocrine growth regulation of human glomerular mesangial cells is primarily mediated by basic fibroblast growth factor.

Authors:  A Francki; P Uciechowski; J Floege; J von der Ohe; K Resch; H H Radeke
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

9.  Periodontal tissue regeneration using fibroblast growth factor-2: randomized controlled phase II clinical trial.

Authors:  Masahiro Kitamura; Keisuke Nakashima; Yusuke Kowashi; Takeo Fujii; Hidetoshi Shimauchi; Takashi Sasano; Toshi Furuuchi; Mitsuo Fukuda; Toshihide Noguchi; Toshiaki Shibutani; Yukio Iwayama; Shogo Takashiba; Hidemi Kurihara; Masami Ninomiya; Jun-ichi Kido; Toshihiko Nagata; Takafumi Hamachi; Katsumasa Maeda; Yoshitaka Hara; Yuichi Izumi; Takao Hirofuji; Enyu Imai; Masatoshi Omae; Mitsuru Watanuki; Shinya Murakami
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

Review 10.  Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications.

Authors:  Thanavel Rajangam; Seong Soo A An
Journal:  Int J Nanomedicine       Date:  2013-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.